Alan Silver, a Back Bay resident, is one of 18 individuals to be chosen to participate in the American Cancer Society’s research grants peer review process for 2013.
These stakeholders have been part of the Society’s grant review process since 1999 and provide a point of view directly from the cancer experience to help ensure the Society makes sound research funding decisions.
No formal science training is required to serve as a stakeholder, but most all have a strong personal interest in cancer research. For Silver who has supported family and friends who are cancer survivors and lost his grandfather and many family members and friends to the disease, serving as stakeholder is one way he can make difference in the fight to end cancer.
The participation of Silver and other stakeholders brings a critical perspective to the grant review process. Each stakeholder joins clinicians, researchers and other scientists for a two-year term to review the more than 1,700 applications submitted to the American Cancer Society each year. Silver will serve as stakeholder in 2013 and 2014. As a dedicated volunteer for the American Cancer Society New England
Division’s Pay-if Research Committee and the AstraZeneca Hope Lodge Center in Boston, Silver understands the importance of his role as stakeholder.
Stakeholders are recruited from around the United States and receive training before being assigned to one or more of the approximately 20 peer review committees in the Society’s Extramural Grants Division. In addition to stakeholders, each committee includes five to 20 researchers, clinicians, and other experts.
“Selecting which research projects will receive American Cancer Society funding is both a critical and difficult process,” said W. Phil Evans M.D., American Cancer Society national volunteer president. “The participation of Stakeholders is akin to a reality check, to assure that each of the hundreds of research proposals is reviewed not only by scientists, but by people who have real-life experience with cancer.”